DSpace Repository

Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment

Show simple item record

dc.contributor.author Ozen, M.E.
dc.contributor.author Yumru, M.
dc.contributor.author Savas, H.
dc.contributor.author Cansel, N.
dc.contributor.author Herken, H.
dc.date.accessioned 2019-08-16T11:33:25Z
dc.date.available 2019-08-16T11:33:25Z
dc.date.issued 2007
dc.identifier.issn 1562-2975
dc.identifier.uri https://hdl.handle.net/11499/4324
dc.identifier.uri https://doi.org/10.1080/15622970600774202
dc.description.abstract Neuroleptic malignant syndrome (NMS) is the rarest and most serious of the neuroleptic-induced movement disorders. We describe a case of neuroleptic malignant syndrome (NMS) associated with the use of ziprasidone. Although conventional neuroleptics are more frequently associated with NMS, atypical antipsychotic drugs like ziprasidone may also be a cause. The patient is a 24-year-old male with a history of schizophrenia who developed signs and symptoms of NMS after 2 days of treatment with an 80-mg/day dose of orally administrated ziprasidone. This case is the earliest (second day of treatment) NMS due to ziprasidone reported in the literature. en_US
dc.language.iso en en_US
dc.relation.ispartof World Journal of Biological Psychiatry en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Neuroleptic malignant syndrome en_US
dc.subject Schizophrenia en_US
dc.subject Treatment en_US
dc.subject Ziprasidone en_US
dc.subject biperiden en_US
dc.subject diazepam en_US
dc.subject olanzapine en_US
dc.subject ziprasidone en_US
dc.subject adult en_US
dc.subject article en_US
dc.subject case report en_US
dc.subject clinical feature en_US
dc.subject disease duration en_US
dc.subject drug urine level en_US
dc.subject human en_US
dc.subject male en_US
dc.subject neuroleptic malignant syndrome en_US
dc.subject neurologic examination en_US
dc.subject rectum temperature en_US
dc.subject schizophrenia en_US
dc.subject treatment duration en_US
dc.subject treatment outcome en_US
dc.subject Adult en_US
dc.subject Antipsychotic Agents en_US
dc.subject Biperiden en_US
dc.subject Diagnosis, Differential en_US
dc.subject Diazepam en_US
dc.subject Drug Therapy, Combination en_US
dc.subject Humans en_US
dc.subject Infusions, Intravenous en_US
dc.subject Male en_US
dc.subject Neuroleptic Malignant Syndrome en_US
dc.subject Neurologic Examination en_US
dc.subject Parkinsonian Disorders en_US
dc.subject Piperazines en_US
dc.subject Thiazoles en_US
dc.title Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment en_US
dc.type Article en_US
dc.identifier.volume 8 en_US
dc.identifier.issue 1 en_US
dc.identifier.startpage 42
dc.identifier.startpage 42 en_US
dc.identifier.endpage 44 en_US
dc.identifier.doi 10.1080/15622970600774202
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.identifier.pmid 17366349 en_US
dc.identifier.scopus 2-s2.0-33847168475 en_US
dc.identifier.wos WOS:000244774600007 en_US

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record